Fortune Journals

Archives of Clinical and Medical Case Reports

ISSN: 2575-9655 Peer Reviewed Open Access
Submit Manuscript →

Intravenous Lidocaine for Opioid-Resistant Pain Control in Metastatic Breast Cancer

Vol 5, Issue 1 Pages 151–155 Published: 18 Jan 2021
Elizabeth Higgins MD*, Ellen Nielsen MD
Article Information
Citation: Elizabeth Higgins, Ellen Nielsen. Intravenous Lidocaine for Opioid-Resistant Pain Control in Metastatic Breast Cancer. Archives of Clinical and Medical Case Reports 5 (2021): 151-155.

DOI: 10.26502/acmcr.96550341

Share
Abstract
A fifty-one-year-old woman presented with pain related to metastatic breast cancer. The palliative care team was consulted for acute pain management intervention. At home, she was taking methadone for pain control. However, shooting pains down her legs had progressed to an unmanageable level, to the point where she was confided to bed. She was admitted to the hospital and was started on a hydromorphone PCA without complete pain control. Intravenous lidocaine was trialed and significantly improved the patient’s pain and decreased the need for other opioid medications. After these results, she was started on a lidocaine drip without side effects noted.
Keywords

Cancer; Intravenous Lidocaine; Metastatic Breast Cancer

Article Details
1. Background
Article Views
2,359
Total Views
Download PDF
Article Details
  • Volume5
  • Issue1
  • Pages151–155
  • Published18 Jan 2021
  • ISSN2575-9655
  • DOI10.26502/acmcr.96550341
Journal

Archives of Clinical and Medical Case Reports

Impact Factor: 5.3
Submit Manuscript
© 2016–2026, Copyrights Fortune Journals. All Rights Reserved.